Researchers investigated mannitol use before and during transportation of patients with intracranial emergencies from peripheral hospitals to tertiary facilities that house neurosurgery departments. The authors found a 22% dosing error rate, with slightly more patients receiving a dose smaller, rather than larger, than the dose range recommended by the Brain Trauma Foundation.